您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > IRL-1620 TFA
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
IRL-1620 TFA
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
包装与价格:
包装价格(元)
10 mM * 1 mL in DMSO电议
500 μg电议
1mg电议
5mg电议
10mg电议
50mg电议

产品介绍
IRL-1620 (TFA) 是高效,选择性的内啡肽受体 (endothelin receptor) B 型激动剂,Ki值为 16 pM。
生物活性

IRL-1620 (TFA) is a potent and selectiveendothelin receptortype B (ETB)agonist with aKiof 16 pM[1].

IC50& Target

IC50: 16 pM (Endothelin receptor B); 19 μM (Endothelin receptor A)[1]

体外研究
(In Vitro)

IRL-1620 (TFA) is the most potent and specific ligand for the ETB receptor (KiETA/ KiETB=120,000) as judged by the Kivalues for ETA (19 μM) and ETB (16 PM) receptors[1].
IRL-1620 (TFA) is 60 times more selective for the ETB receptor than ET-3 (KiETA/ KiETB=1,900)[1].

体内研究
(In Vivo)

IRL-1620 (TFA) (1-100 nM) induces contractions of the guinea pig trachea. The effective concentration that produces 30 % of 60 mM KCI-induced contraction is estimated to be 28 nM for IRL-1620[1].
IRL-1620 (TFA) (1-100 nM) increases cytosolic Ca2+in the vascular endothelium ([Ca]E) with little effect on resting muscle tone, and relaxes the norepinephrine-stimulated tone with an increase in [Ca]E, in rat aorta,[1].
IRL-1620 (TFA) improves both acquisition (learning) and retention (memory) on the water maze task and enhances angiogenic and neurogenic remodeling. Rats treated with IRL-1620 significantly reduces the cognitive impairment induced by Aβ. IRL-1620 treatment enhances the number of blood vessels labeled with VEGF compared to vehicle treatment[2].
IRL-1620 (TFA), restores analgesic tolerance to morphine and oxycodone, but it does not affect morphine and oxycodone induced decrease in NGF/PI3K expression. IRL-1620 attenuates opioid tolerance without the involvement of NGF/PI3K pathway[3].

分子量

1934.97

性状

Solid

Formula

C88H118F3N17O29

Sequence

{Suc}-Asp-Glu-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp

Sequence Shortening

{Suc}-DEEAVYFAHLDIIW

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Sealed storage, away from moisture and light

Powder-80°C2 years
-20°C1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

溶解性数据
In Vitro: 

DMSO : 50 mg/mL(25.84 mM;Need ultrasonic)

H2O :< 0.1 mg/mL (ultrasonic)(insoluble)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM0.5168 mL2.5840 mL5.1680 mL
5 mM0.1034 mL0.5168 mL1.0336 mL
10 mM0.0517 mL0.2584 mL0.5168 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture and light)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。